Search Results

Pharm Country

Genisphere’s Collaborators Publish Research in Brain

Genisphere reported a publication in the journal Brain that demonstrates a novel 3DNA® nanocarrier shown to carry a peptide drug through the body and precisely target microglia cells in the brain

November 1, 2019

·

3 min read

Business

Genisphere and University Hospitals Collaborate on Novel Pancreatic Cancer Treatments

Genisphere LLC and University Hospitals Cleveland Medical Center announced a partnership to study and develop unique strategies to treat pancreatic cancer.

August 27, 2019

·

4 min read

Business

Genisphere and Sidney Kimmel Cancer Center at Jefferson Health Collaborate on the Treatment of Pancreatic Cancer

Genisphere LLC and the Sidney Kimmel Cancer Center at Jefferson Health announced a research collaboration to develop novel approaches to treat pancreatic cancer.

May 30, 2018

·

3 min read

Drug Development

Genisphere Reports Safety of 3DNA Nanocarrier

Genisphere announced positive results from a non-GLP safety study evaluating dose escalation and repeated dose toxicity of the company’s 3DNA nanocarrier in Sprague Dawley rats.

November 15, 2017

·

3 min read

Pharm Country

Genisphere Pursues Neurotherapeutics under Collaboration Agreement with Inserm

Genisphere has signed a collaborative research agreement with The Institut national de la santé et de la recherche médicale (Inserm, The French National Institute of Health & Medical Research) to study targeted nanotherapeutics for neurological disease.

October 17, 2017

·

2 min read

Pharm Country

Genisphere Raises $7M to Advance 3DNA Drug Delivery System

Genisphere completed the raise to support accelerating interest in advancing its 3DNA scaffold into the clinic and enabling follow-on studies and programs currently underway with biotech and pharma partners.

November 1, 2017

·

2 min read

Business

Genisphere Appoints Biopharmaceutical Veteran, Brian P. McVeigh, to Its Board of Directors

Brian P. McVeigh has joined the company’s Board of Directors, bringing expertise to expand activities in business development and investment management.

December 6, 2018

·

3 min read

Pharm Country

Genisphere Reports Safety of 3DNA Nanocarrier

The study demonstrated no adverse clinical findings after repeated intravenous administration of the maximum achievable dose of 3DNA nanocarrier.

November 14, 2017

·

3 min read

Business

Genisphere Begins Collaborative And Sponsored Research Program With University of Maryland

April 26, 2017

·

3 min read

DNA Nanotechnology Market Expected to Grow at a CAGR of 24.67% from 2024 to 2031

Global DNA Nanotechnology Market is valued at US$ 4.34 Bn in 2023, and it is expected to reach US$ 24.29 Bn by 2031, with a CAGR of 24.67% during the forecast period of 2024-2031.

April 22, 2024

·

4 min read